Microarray analysis revealed that several mevalonate pathway genes appeared to be transcriptionally upregulated in ASPP2 depleted HCC-LM3 cells (Fig. 1a), and we hypothesized that ASPP2 is an upstream regulator of mevalonate pathway, probably through regulation of SREBP-2. The gene discussed is TP53BP2; the disease is hepatocellular carcinoma.